Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 4
2019 4
2020 10
2021 11
2022 12
2023 15
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of COVID-19 and risk factors in patients with cancer.
Sengar M, Chinnaswamy G, Ranganathan P, Ashok A, Bhosale S, Biswas S, Chaturvedi P, Dhamne C, Divatia J, D'Sa K, Jain H, Laskar S, Moulik NR, Mummudi N, Nair S, Nayak L, Nayak P, Patkar S, Pawaskar P, Ramaswamy A, Shetty O, Singh A, Sridhar E, Thorat J, Badwe R, Pramesh CS; TMH COVID-19 action group. Sengar M, et al. Among authors: nayak l. Nat Cancer. 2022 May;3(5):547-551. doi: 10.1038/s43018-022-00363-4. Epub 2022 Apr 4. Nat Cancer. 2022. PMID: 35379984
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma.
Bagal B, Gokarn A, Punatar S, Das S, Bonda A, Nayak L, Chichra A, Kannan S, Mathew LJ, Tembhare P, Patkar N, Poojary M, Ojha S, Subramanian PG, Gujral S, Khattry N. Bagal B, et al. Among authors: nayak l. Int J Hematol. 2020 Dec;112(6):835-840. doi: 10.1007/s12185-020-02973-z. Epub 2020 Sep 2. Int J Hematol. 2020. PMID: 32876851
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.
Jain A, Nayak L, Kulkarni UP, Mehra N, Yanamandra U, Kayal S, Damodar S, John JM, Mehta P, Singh S, Munot P, Selvarajan S, Radhakrishnan V, Lad D, Kapoor R, Dubashi B, Bharath RS, Jain H, Jayachandran PK, Lakshmanan J, Mani T, Thorat J, Das S, Karunamurthy O, George B, Sengar M, Malhotra P. Jain A, et al. Among authors: nayak l. Blood Cancer J. 2022 Jan 5;12(1):2. doi: 10.1038/s41408-021-00599-w. Blood Cancer J. 2022. PMID: 34987161 Free PMC article. No abstract available.
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.
Tembhare PR, Sriram H, Khanka T, Gawai S, Bagal B, Ghogale SG, Deshpande N, Girase K, Patil J, Hasan SK, Shetty D, Ghosh K, Chatterjee G, Rajpal S, Patkar NV, Jain H, Punatar S, Gokarn A, Nayak L, Mirgh S, Jindal N, Sengar M, Khattry N, Subramanian PG, Gujral S. Tembhare PR, et al. Among authors: nayak l. Hemasphere. 2024 Apr 1;8(4):e63. doi: 10.1002/hem3.63. eCollection 2024 Apr. Hemasphere. 2024. PMID: 38566804 Free PMC article.
"Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country".
Jobanputra K, Nayak L, Jain H, Shet T, Epari S, Bonda VNA, Thorat J, Bagal B, Laskar S, Rangarajan V, Agrawal A, Gujral S, Khanna N, Goda JS, Sengar M. Jobanputra K, et al. Among authors: nayak l. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e898-e906. doi: 10.1016/j.clml.2022.06.003. Epub 2022 Jun 6. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35810145
Role of Curcumin in Reducing Toxicities Associated With Mucosal Injury Following Melphalan-Based Conditioning in Autologous Transplant Setting.
Punatar S, Katti K, Rajamanickam D, Patil P, Dhakan C, Bagal B, Gokarn A, Bonda A, Nayak L, Gurjar M, Kannan S, Chiplunkar S, Gota V, Khattry N. Punatar S, et al. Among authors: nayak l. Cell Transplant. 2022 Jan-Dec;31:9636897221086969. doi: 10.1177/09636897221086969. Cell Transplant. 2022. PMID: 35435039 Free PMC article.
53 results